학술논문
GRC 54276, a novel small molecule inhibitor of HPK1 has entered phase 1/2 clinical trial insolid malignancies and Hodgkin's/non Hodgkin's lymphoma
Document Type
Journal
Author
Mandadi, Sravan; Das, Sanjib; Bajpai, Malini; Saini, Jagmohan; Chinnapattu, Murugan; Patale, Sanjay; Patil, Sandip; Kadlag, Nanasaheb; Waghmare, Nayan; Gavhane, Balasaheb; Deshpande, Ameya; Dahale, Dnyaneshwar; Kattige, Vidya; Pangre, Priyanka; Singh, Namrata; Kashyap, Ekta; Marathe, Megha; Mani, Jiju; Akarte, Atul; Misra, Chandrasekhar; Das, Subhadip; Singh, Anuj; Lambade, Pandurang; Das, Avratanu; Tirumalasetty, Chaitanya; Patole, Raju; Biswas, Nilanjana; Karande, Vikas; Shah, Heta; Behera, Dayanidhi; Jain, Pankaj; Sancheti, Pavankumar; Pawar, Pramod; Kr, Vinod; Udupa, Venkatesha; Chaudhari, Sachin S.; Gowda, Nagaraj; Iyer, Pravin S.
Source
Subject
Language
English
ISSN
15387445